Dmitri Bobilev SEC EDGAR Filings (CIK 0001952201)

SEC EDGAR filings, ownership reports, and insider transactions for Dmitri Bobilev.

Business address
C/O Fusion Pharmaceuticals Inc., 270 Longwood Rd. South, Hamilton, Canada (Federal Level), L8P 0A6
Get insider transactions for this reporting owner
Dmitri Bobilev has filed 4 SEC EDGAR filings since 07 Nov 2022

Latest Filings

Recent SEC filings for Dmitri Bobilev including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 04 Jun 2024 04 Jun 2024 001-39344
4 Open 4 document View SEC filing for 4 4 05 Jan 2024 04 Jan 2024 001-39344
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 07 Nov 2022 07 Nov 2022 001-39344
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 Nov 2022 07 Nov 2022 001-39344

About this filer

Dmitri Bobilev files with the SEC under CIK 0001952201. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages